THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL
Objective: to study the rate of metabolic syndrome (MS) and its components among gout patients in different regions of the Russian Federation. Subjects and methods. This cross-sectional multicenter study enrolled 2277 gout patients, including 1963 (86.2%) men and 314 (13.8%) women, from 12 independe...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2012-12-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1175 |
| _version_ | 1797862778317307904 |
|---|---|
| author | V G Barskova Maksim Sergeyevich Eliseyev I S Denisov M E Eliseyeva O A Belikov G R Fadiyenko F S Zharskaya O P Polkovnikova A N Kalyagin M V Sklyanova E A Shvetsova L A Knyazeva I M Marusenko S E Myasoedova E A Kozhevnikova M N Petrova T A Raskina M V Koroleva V V Tyrenko A A Al-Nuvairakh A G Khanov |
| author_facet | V G Barskova Maksim Sergeyevich Eliseyev I S Denisov M E Eliseyeva O A Belikov G R Fadiyenko F S Zharskaya O P Polkovnikova A N Kalyagin M V Sklyanova E A Shvetsova L A Knyazeva I M Marusenko S E Myasoedova E A Kozhevnikova M N Petrova T A Raskina M V Koroleva V V Tyrenko A A Al-Nuvairakh A G Khanov |
| author_sort | V G Barskova |
| collection | DOAJ |
| description | Objective: to study the rate of metabolic syndrome (MS) and its components among gout patients in different regions of the Russian Federation. Subjects and methods. This cross-sectional multicenter study enrolled 2277 gout patients, including 1963 (86.2%) men and 314 (13.8%) women, from 12 independent medical centers in different regions of the Russian Federation. The patients over 18 years of age who met the classification criteria for gout, elaborated by S. Wallace et al., were included. The diagnosis of MS was established on the basis of Adult Treatment Panel III (ATP III) criteria. The presence of MS, its individual components and comorbidities were recorded. Results. The total rate of MS in the patients with gout was 57%; however, it varied substantially (from 15 to 77%) in different centers. Among the comorbidities, arterial hypertension was most common (in three fourths of the patients), coronary heart disease (CHD) and type 2 diabetes mellitus were less common (43 and 25%, respectively); 15% of the patients had sustained myocardial infarction, renal and cardiac failure was also observed in 15%. In the gout patients, MS was associated with the presence of CHD. Conclusion. The patients with gout were observed to have a high rate of MS (57%), its components, and cardiovascular diseases. The findings suggest that there is a relationship between the presence of MS and the development of CHD. |
| first_indexed | 2024-04-09T22:26:08Z |
| format | Article |
| id | doaj.art-5b09765dc8c343f08abc5b21d167cb2e |
| institution | Directory Open Access Journal |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| last_indexed | 2024-04-09T22:26:08Z |
| publishDate | 2012-12-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj.art-5b09765dc8c343f08abc5b21d167cb2e2023-03-22T13:45:47ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922012-12-01506151810.14412/1995-4484-2012-12871115THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIALV G BarskovaMaksim Sergeyevich EliseyevI S DenisovM E EliseyevaO A BelikovG R FadiyenkoF S ZharskayaO P PolkovnikovaA N KalyaginM V SklyanovaE A ShvetsovaL A KnyazevaI M MarusenkoS E MyasoedovaE A KozhevnikovaM N PetrovaT A RaskinaM V KorolevaV V TyrenkoA A Al-NuvairakhA G KhanovObjective: to study the rate of metabolic syndrome (MS) and its components among gout patients in different regions of the Russian Federation. Subjects and methods. This cross-sectional multicenter study enrolled 2277 gout patients, including 1963 (86.2%) men and 314 (13.8%) women, from 12 independent medical centers in different regions of the Russian Federation. The patients over 18 years of age who met the classification criteria for gout, elaborated by S. Wallace et al., were included. The diagnosis of MS was established on the basis of Adult Treatment Panel III (ATP III) criteria. The presence of MS, its individual components and comorbidities were recorded. Results. The total rate of MS in the patients with gout was 57%; however, it varied substantially (from 15 to 77%) in different centers. Among the comorbidities, arterial hypertension was most common (in three fourths of the patients), coronary heart disease (CHD) and type 2 diabetes mellitus were less common (43 and 25%, respectively); 15% of the patients had sustained myocardial infarction, renal and cardiac failure was also observed in 15%. In the gout patients, MS was associated with the presence of CHD. Conclusion. The patients with gout were observed to have a high rate of MS (57%), its components, and cardiovascular diseases. The findings suggest that there is a relationship between the presence of MS and the development of CHD.https://rsp.mediar-press.net/rsp/article/view/1175goatmetabolic syndromecardiovascular diseasesmulticenter trial |
| spellingShingle | V G Barskova Maksim Sergeyevich Eliseyev I S Denisov M E Eliseyeva O A Belikov G R Fadiyenko F S Zharskaya O P Polkovnikova A N Kalyagin M V Sklyanova E A Shvetsova L A Knyazeva I M Marusenko S E Myasoedova E A Kozhevnikova M N Petrova T A Raskina M V Koroleva V V Tyrenko A A Al-Nuvairakh A G Khanov THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL Научно-практическая ревматология goat metabolic syndrome cardiovascular diseases multicenter trial |
| title | THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL |
| title_full | THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL |
| title_fullStr | THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL |
| title_full_unstemmed | THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL |
| title_short | THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL |
| title_sort | rate of metabolic syndrome and comorbidities in patients with gout data of a multicenter trial |
| topic | goat metabolic syndrome cardiovascular diseases multicenter trial |
| url | https://rsp.mediar-press.net/rsp/article/view/1175 |
| work_keys_str_mv | AT vgbarskova therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT maksimsergeyevicheliseyev therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT isdenisov therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT meeliseyeva therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT oabelikov therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT grfadiyenko therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT fszharskaya therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT oppolkovnikova therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT ankalyagin therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT mvsklyanova therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT eashvetsova therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT laknyazeva therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT immarusenko therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT semyasoedova therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT eakozhevnikova therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT mnpetrova therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT taraskina therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT mvkoroleva therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT vvtyrenko therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT aaalnuvairakh therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT agkhanov therateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT vgbarskova rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT maksimsergeyevicheliseyev rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT isdenisov rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT meeliseyeva rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT oabelikov rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT grfadiyenko rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT fszharskaya rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT oppolkovnikova rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT ankalyagin rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT mvsklyanova rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT eashvetsova rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT laknyazeva rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT immarusenko rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT semyasoedova rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT eakozhevnikova rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT mnpetrova rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT taraskina rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT mvkoroleva rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT vvtyrenko rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT aaalnuvairakh rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial AT agkhanov rateofmetabolicsyndromeandcomorbiditiesinpatientswithgoutdataofamulticentertrial |